Workflow
Earnings Estimate Revision
icon
搜索文档
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
ZACKS· 2025-07-29 15:01
核心财务预期 - 预计季度每股收益1.23美元 同比增长35.2% [3] - 预计季度收入2.8612亿美元 同比增长23.7% [3] - 过去30天内共识EPS预期上调1.48%至当前水平 [4] 盈利惊喜预测 - 最准确估计值高于共识预期 形成正4.07%的ESP预期差 [12] - 结合Zacks第三级评级 历史显示该组合有近70%概率实现盈利超预期 [10][12] - 公司连续四个季度均超越EPS预期 最近季度实际EPS 1.11美元超预期16.84% [13][14] 市场影响机制 - 实际业绩与预期对比将显著影响短期股价走势 [1] - 超出预期可能推动股价上涨 未达预期可能导致下跌 [2] - 管理层在电话会议中对业务状况的讨论将决定价格变动的可持续性 [2] 预测方法论 - Zacks盈利ESP模型通过对比最准确估计与共识预期来预测偏差 [8] - 分析师在财报发布前修订的估计包含最新信息 通常更具准确性 [8] - 该模型仅对正ESP读数具有显著预测能力 [9]
How Much Upside is Left in Omnicom (OMC)? Wall Street Analysts Think 25.37%
ZACKS· 2025-07-29 14:56
股价表现与目标价分析 - Omnicom(OMC)过去四周股价上涨3.7%至74.63美元 但华尔街分析师平均目标价93.56美元显示仍有25.4%潜在上涨空间 [1] - 9个短期目标价的标准差为13.43美元 最低目标价78美元(较现价+4.5%) 最高目标价116美元(较现价+55.4%) 标准差反映分析师预测分歧程度 [2] - 分析师共识目标价虽受投资者关注 但单纯依赖该指标可能误导投资决策 需结合其他因素综合判断 [3][10] 盈利预测修正 - 分析师普遍上调EPS预测 近期30天内4次上调且无下调 推动Zacks共识预期增长1.7% [11][12] - 盈利预测修正趋势与短期股价走势存在强相关性 当前正向修正趋势支撑股价上行逻辑 [11] - OMC获Zacks评级2(买入) 位列4000只股票前20% 显示其短期上涨潜力 [13] 目标价可信度研究 - 学术研究表明分析师目标价误导性大于指导性 实际预测准确性有限 [7] - 华尔街分析师可能因商业利益(如维护客户关系)设定过度乐观目标价 [8] - 低标准差目标价集群反映分析师共识度高 可作为研究基本面驱动力的起点 [9] 综合投资建议 - 目标价方向性指引仍具参考价值 但需保持审慎态度 避免作为唯一决策依据 [14] - 结合盈利预测上修趋势与Zacks评级等多项指标 公司股价存在实质性上涨动力 [11][13]
Seeking Clues to Check Point (CHKP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-29 14:16
With that in mind, let's delve into the average projections of some Check Point metrics that are commonly tracked and projected by analysts on Wall Street. The consensus among analysts is that 'Revenues- Total revenues from products and security subscriptions' will reach $423.58 million. The estimate suggests a change of +8.7% year over year. It is projected by analysts that the 'Revenues- Software updates and maintenance' will reach $237.06 million. The estimate points to a change of -0.2% from the year-ag ...
Ahead of Ameren (AEE) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-07-29 14:16
In its upcoming report, Ameren (AEE) is predicted by Wall Street analysts to post quarterly earnings of $1.00 per share, reflecting an increase of 3.1% compared to the same period last year. Revenues are forecasted to be $1.88 billion, representing a year-over-year increase of 10.8%. The consensus EPS estimate for the quarter has undergone an upward revision of 1.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial est ...
What Analyst Projections for Key Metrics Reveal About Chevron (CVX) Q2 Earnings
ZACKS· 2025-07-29 14:16
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short- term price performance of a stock. While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during t ...
Unlocking Q2 Potential of Regeneron (REGN): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-07-29 14:16
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short- term price performance of a stock. While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into an ...
Insights Into T. Rowe (TROW) Q2: Wall Street Projections for Key Metrics
ZACKS· 2025-07-29 14:16
Analysts forecast 'Net revenues- Investment advisory fees' to reach $1.56 billion. The estimate indicates a change of -1.8% from the prior-year quarter. The consensus estimate for 'Net revenues- Investment Advisory Fees- Alternatives' stands at $79.68 million. The estimate indicates a year-over-year change of -13.1%. Wall Street analysts forecast that T. Rowe Price (TROW) will report quarterly earnings of $2.11 per share in its upcoming release, pointing to a year-over-year decline of 6.6%. It is anticipate ...
Gear Up for CBOE (CBOE) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-29 14:16
Wall Street analysts forecast that CBOE Global (CBOE) will report quarterly earnings of $2.42 per share in its upcoming release, pointing to a year-over-year increase of 12.6%. It is anticipated that revenues will amount to $572.24 million, exhibiting an increase of 11.4% compared to the year-ago quarter. The consensus EPS estimate for the quarter has been revised 0.7% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their ini ...
Unveiling Tyler Technologies (TYL) Q2 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-29 14:16
Wall Street analysts forecast that Tyler Technologies (TYL) will report quarterly earnings of $2.78 per share in its upcoming release, pointing to a year-over-year increase of 15.8%. It is anticipated that revenues will amount to $586.23 million, exhibiting an increase of 8.4% compared to the year-ago quarter. Analysts forecast 'Revenue- Recurring' to reach $501.75 million. The estimate indicates a change of +11.8% from the prior-year quarter. Over the last 30 days, there has been no revision in the consens ...
Exxon (XOM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2025-07-29 14:16
Wall Street analysts expect Exxon Mobil (XOM) to post quarterly earnings of $1.49 per share in its upcoming report, which indicates a year-over-year decline of 30.4%. Revenues are expected to be $82.82 billion, down 11% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 10.7% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Prior to a company's ...